Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Download on the App Store

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episodes

  • Mahesh Narayanan, Program Director & Venture Partner at Newchip

    Mahesh Narayanan is an entrepreneur in biotechnology with extensive experience in the healthcare and life sciences industry, and a strong focus on business development and business start-up strategies. As an active member of the Small Business community, he provides business and scientific guidance in the development of therapeutics and medical devices. He has experience in taking an idea from concept to consumers and considerable knowledge on patents, business plans, fundraising, and incorporation. Mahesh received his Master’s in Biotechnology from the University of Pennsylvania and his bachelor’s degrees in History and Pre-Medical Sciences from Boston University.

    36 min
  • Hernan Burgos, Director of Sales Development for Smile CDR

    Hernan Burgos is an IT Professional with over 30 years of experience working with various organizations including government, law, and health. Hernan has been the Director of Sales Development for Smile CDR for the last 4 years, with a growth of 300% during 2020 and expecting a 500% growth for 2021. Smile CDR has clients in 15 countries with a forecast of reaching 20+ countries by 2022. We are living through a historical moment in the Health Information World Systems, for the first time the entire world is adopting one health standard to reach interoperability and reduce development and operational costs.

    37 min
  • Marie O’Malley, Senior Director of Supplier Outreach at Medtronic

    Marie O’Malley is the Senior Director of Supplier Outreach for Medtronic, responsible for developing and executing long-term Medtronic supplier outreach programs, including efforts around Responsible Supply Management and Supplier Diversity. In her role, she also liaises with various government officials and development boards to advance Medtronic’s Supplier relations.  Marie also leads the team to advance communication strategies for Medtronic’s Global Supply Management organization. Marie joined Medtronic through the Bard USCI/AVE merger and has been with Medtronic for 25 years. Marie has progressed through several positions with increasing responsibility in a number of functions including Finance, Sales & Contract Administration, Customer Service, Global Supply Chain, and Supply Management roles.  Marie has an MBA from Bentley University and a bachelor’s in Finance from Binghamton University in New York.  She also maintains credentials as a CPSD (Certified Professional in Supplier Diversity). Certified Management Accountant, and CPIM (Certified in Production and Inventory Management). Marie currently serves as Chair on the Board of Directors of MassMEDIC representing Medtronic.  MassMEDIC is an association of medical device manufacturers in the Commonwealth with over 400 members including manufacturers, product developers, suppliers, research institutions, and academic health centers.  Marie was recognized in the 2018 and 2019 top 100 list of women executive leaders in the MedTech industry.

    28 min
  • Charlie Webb, Founder & President at Van der Stahl Scientific, Inc

    Charlie Webb is the Founder and President of Van der Stahl Scientific, a medical device packaging and texting machine provider. He also hosts the popular Podcast “SPOT Radio” (sterile packaging on track). Charlie earned his BS degree in Management at the University of Redlands and completed the medical device development program at the Andersen graduate school of management at UCLA. Charlie is a “lifetime” certified packaging professional “CPPL” certified through the institute of packaging professionals as well as a “Six Sigma Master Black Belt”. As a member of a scientific review board, he co-developed micro-surgical devices that broke away from conservative innovation models. Charlie has been in sterile device packaging for 26 years and has been involved in numerous FDA and ISO audits as a regulatory advisor.  

    40 min
  • Daven Patel, CEO & Dr. Anand Srivastava, Chairman and Cofounder at Global Institute of Stem Cell Therapy and Research (GIOSTAR)

    Mr. Deven Patel, the CEO, President, and Cofounder of Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A. GIOSTAR was formed with the vision to provide affordable stem cell-based therapies to the masses around the world suffering from degenerative or genetic diseases and unable to afford today’s high cost of treatment.  Mr. Patel has served as the CEO, President, and Board of Directors in highly comprehensive industries such as Healthcare, Stem Cell Research, Architectural, General Construction, Alternative Energy, and Multifaceted Internet industries. Mr. Patel has served as the President of Federation of India Associations San Diego (FIA-SD) Mr. Patel has also served in key positions of several public and private organizations such as GIOSTAR Foundation, Asian and Pacific American Coalition (APAC), Asian Business Association, Cambridge Companies, Reality Changers, Global Organization of People of Indian Origin. He has also served as Vice President of the newly formed San Diego United Lion’s Club.  Mr. Patel has served as the founding President of the Asian and Pacific American Coalition (APAC) representing San Diego API communities from nine Asian countries and spearheaded its efforts in 2011 at San Diego City Hall to create the new 9th City Council District in the City of San Diego to be an Asian Pacific American influenced district, first time in the history of San Diego through the redistricting process. 

    Dr. Anand Srivastava has been associated with leading universities and research institutions in the USA. In affiliation with University of California San Diego Medical College (UCSD), University of California Irvine Medical College (UCI), Salk Research Institute, San Diego, Burnham Institute For Medical Research, San Diego, University of California Los Angeles Medical College (UCLA), USA has helped develop several research programs and has an extensive research experience in the field of stem cell which is documented by several publications in revered scientific journals.  Dr. Anand Srivastava’s success has its root in his unique background of expertise in Stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cells, tissue targeting, gene therapy, and clinical research. There are many scientists who can work in a narrowly defined field but few have the broad and multidisciplinary experience to carry out clinical research in a field as challenging as Stem cell biology, cancer, and gene therapy field. Dr. Anand Srivastava’s wide-spectrum expertise is rare in clinical research and perfectly crafted to fit ideally with the GIOSTAR projects for stem cell transplant, cancer, and gene therapy research. 

    39 min
  • Jonatan Pantanowitz, EVP Business Development at Livinguard

    During 2020 Jonathan has been in a crucial leadership position, steering Livinguard through a unique inflection point in its business and building the teams to drive brand building, communications, and sales for Livinguard’s antiviral, reusable face masks, and several other new products. Jonathan has a wealth of business and leadership experience, having spent the previous 14 years with 3M, where amongst other roles he was Managing Director, 3M Israel. As an innovation enthusiast, he established the first connections between 3M and the Israel Innovation ecosystem and held the position of New Tech Scout for 3M New Ventures in Israel. During his tenure, he held board seats with 2 start-ups and was involved in several other investments on behalf of 3M. A sports enthusiast in his spare time, Jonathan volunteers as a board member of the Israel Cycling Federation. Jonathan holds a BA in Business & Communication from the Tel Aviv College of Management and an MBA from The Edinburgh Business School.

    41 min
  • Michael Hill, Former Vice President, Science & Technology and Innovation at Medtronic

    Dr. Michael Hill is a global-minded senior executive with a history of success creating meaningful, patient-inspired, medical device technology innovations. He is a skilled entrepreneur demonstrating repeat innovation execution from idea/discovery to commercial scale. He was inducted in 2012 as an American Institute of Medical and Biological Engineering Fellow and awarded the Distinguished Engineering Alumni from Duke University in 2013. He possesses deep domain knowledge of science and technology and has more than 27 years of experience with research, product development, and clinical research/regulatory. He is adept in successfully leading large global organizations, as well as multiple programs and projects, to achieve target goals. He has a thorough understanding of the fundamentals related to global healthcare systems to deliver impactful transformative innovations. Dr. Hill received his BSE [Biomedical and Electrical Engineering] and BS [Mathematics] Degrees from Duke University, MS, and Ph.D. [Biomedical Engineering] Degrees from Case Western Reserve University, and MBA [Management] Degree from the University of St. Thomas.

    39 min
  • Javier Pastor, Vice President & General Manager of Mexico/Central America at Elekta

    Seasoned Healthcare Executive with proven skills for people development, organizational transformation, and motivation with 15 years delivering above and beyond financial results. Mr. Pastor has an exemplary external focus and is highly collaborative with customers and a wide range of stakeholders to match the company with customers’ needs. He is very adaptive and able to connect strategy to purpose in a way that fosters commitment, Javier has the imagination to innovate and the courage to implement organizational changes and go to market strategies highly inclusive and able to build great teams.

    42 min
  • John Reites, CEO at THREAD

    Executive entrepreneur turned digital health entrepreneur, his career includes 18+ years leading global drug development, clinical research, and decentralized trials for life science organizations.

     As CEO of THREAD, John leads their efforts to change the way clinical research is conducted focused on decentralized approaches, enabling the use of their one platform for conducting modern research studies and leading partnerships with their customers. After launching and growing THREAD, they were acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for our customers.

    Named one of the Top 100 Influencers in Digital Health, John also provides expertise and execution experience in digital health, clinical trials, and decentralized, remote, virtual, community-based clinical research. John enjoys being a keynote speaker at global industry events, a guest lecturer at Duke University on digital health/innovation/entrepreneurship, and a published author featured in various conferences, journals, articles, and media outlets.

    50 min
  • Thomas Celerier, Marcel Gradidge & Gautam Narayan

    Thomas Celerier is heading their Healthcare, MedTech, and Life Sciences business, teams, and portfolio of clients for the Palo Alto Offices, Marcel Gradidge is a Director in the Business Advisory unit in the Silicon Valley Market and Gautam Narayan is a leader in the Emerge Supply Chain Division. All of them come from a diverse background managing global projects and teams and with experience in international relationships, with careers, professional and personal lives spanning multiple locations such as Australia, Colombia, Mexico, South Africa, Europe, India, and North America.

    47 min

About Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

From the publisher's feed

Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech,…